ArticleCureus2024
Therapeutic Outcomes of Biomodulation With Radio Electric Asymmetric Conveyer (REAC) Technology in an 80-Year-Old Female: A Case Report on Anti-cellulite, Circulatory, and Metabolic Optimization Treatments.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report examines the therapeutic outcomes of Radio Electric Asymmetric Conveyer (REAC) anti-cellulite treatment (ACT), circulatory optimization (CO), and metabolic optimization (MO) in an 80-year-old female with multiple chronic conditions, including morbid obesity, type 2 diabetes mellitus, hypertension, and a history of deep vein thrombosis. Each treatment protocol was administered in 18-session cycles. The patient experienced substantial improvements in edema, erythema, pain, and mobility, with a reduced reliance on analgesics. Moreover, there were significant enhancements in sleep quality, mood, mental clarity, and a 7-kg weight loss. These results suggest that REAC ACT, CO, and MO treatments effectively addressed not only localized symptoms but also contributed to broader systemic health improvements by promoting cellular homeostasis and energy production. This case highlights the potential of these REAC treatments as non-invasive and effective options for elderly patients with complex health profiles, encouraging further studies to establish standardized treatment protocols.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.